Skye Bioscience, Inc.
SKYE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$27 | -$38 | -$19 | -$9 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $8 | $1 | $1 | $1 |
| Change in WC | -$3 | -$0 | -$1 | $1 |
| Other Non-Cash | -$5 | $23 | $7 | $0 |
| Operating Cash Flow | -$25 | -$14 | -$13 | -$6 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $5 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $1 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $7 | -$0 | $0 |
| Investing Cash Flow | -$0 | $7 | $5 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $5 | -$0 | $0 |
| Stock Issued | $84 | $12 | $0 | $6 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$0 | $0 | $7 |
| Financing Cash Flow | $84 | $16 | -$0 | $13 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $58 | $9 | -$8 | $7 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $10 | $1 | $9 | $2 |
| End Cash | $68 | $10 | $1 | $9 |
| Free Cash Flow | -$27 | -$14 | -$13 | -$7 |